Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome
about
The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitisCryptococcus and Phagocytes: Complex Interactions that Influence Disease OutcomePleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature reviewPredictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune statusPulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosisLipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosisCryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortalityCentral nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings.Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis.Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients.Use of a suspension array for rapid identification of the varieties and genotypes of the Cryptococcus neoformans species complex.Epidemiology of Cryptococcosis and Cryptococcal Meningitis in a Large Retrospective Cohort of Patients After Solid Organ TransplantationCryptococcal meningitis: epidemiology and therapeutic options.Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).Cryptococcosis in patients with hematological diseases: a 14-year retrospective clinical analysis in a Chinese tertiary hospital.Invasive fungal infections after renal transplantation.Identification and characterization of an SKN7 homologue in Cryptococcus neoformans.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Calcineurin is essential for survival during membrane stress in Candida albicans.STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn superoxide dismutaseInvasive fungal infections in solid organ transplant recipients.Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformansAntibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantationErgosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.Overexpression of TUF1 restores respiratory growth and fluconazole sensitivity to a Cryptococcus neoformans vad1Delta mutant.Epidemiology of invasive fungal infections in the mediterranean areaProtective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazoleDonor transmission of Cryptococcus neoformans presenting late after renal transplantationDiagnosis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-2)Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection.STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformansA copper hyperaccumulation phenotype correlates with pathogenesis in Cryptococcus neoformans.Cryptococcosis in solid organ transplant recipients: current state of the scienceA proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.Quantitation of cellular components in Cryptococcus neoformans for system biology analysis
P2860
Q24538877-ECA9A6AB-992D-4BA5-9429-073C101E90ACQ26767978-173F8A5C-9797-433D-ADDF-0E2BD1298331Q26782063-E4043FF8-7EDA-4182-ACDC-A3AD42AAA793Q28488912-4F0AD6E0-3954-46F9-9CC0-42FDBD56849EQ30426015-8DCE67D0-2887-4C1A-84CC-7526E48AA0CAQ30426041-9477F289-6F6E-4EA5-9518-730A08928968Q30433949-771A4C18-BA04-4AA8-BCD9-4D89563891D2Q30438524-DD18D225-A32C-4654-8BA1-FD470B8ACFFBQ30438585-0E9B0F49-A858-48D0-A2F3-54ECAEF59B5CQ30441628-A2D2687D-DA0B-4DE4-B881-5B7FF6496563Q30443276-766C2C82-AE66-4E51-8CFE-A5F6306DD0EFQ33221146-25D66579-676A-46AA-93D0-53D64BF82DD8Q33629107-CAE1B2D3-3D59-4B51-BD41-0AE3F72E01A0Q33633343-1D6C5D6C-5EDD-4B0F-A182-71BE825AF4F3Q33859215-5405391D-9F8D-4DE3-8295-B26B09BC0D48Q33868567-64F9236C-3733-4D0A-9D8A-9D6386DCF098Q33871837-1D48D147-55D0-445E-890C-C937723060DBQ33946817-EDF28DFE-5DCD-405B-A024-D174F402A7CCQ34020746-6843EF6D-0A0A-4C3D-9349-5B7DD41767EEQ34085830-A53E8E07-618A-4DF0-B984-6AA2156EB059Q34289451-0F244D09-1B93-47E1-AA4D-DB4AA45EE3CCQ34442091-39A130BE-9EF5-4AF3-A809-6900C5E8BB23Q34461693-15788150-B951-4047-8D7D-20352B00969DQ34680995-7DEA0CAC-8FB2-4A3A-8E48-7DEC1DE980C0Q34720443-1BFE5D30-1B31-4427-B757-37FFB79036BDQ34735206-E0B52FFB-E09E-441E-A305-8B8D23430EE0Q34746960-C758D369-C50E-4918-9186-51A3DDBEE663Q35010686-221637B9-C05A-4F99-867F-5CCAC6BF0F13Q35066122-D1443FAA-B1CD-42F4-AAA5-4BEEE4267D63Q35552662-894A3531-715F-4C53-ADE3-C397EAFBF161Q35608463-5538F5F8-1357-4B84-A2E4-D66DB9E496EAQ35678921-D73553C6-30C3-494F-9D83-AF463BDDFA5EQ36192774-096E92E7-C989-46CB-8995-100F73686FF7Q36228216-24724F7F-2539-46F2-B531-ADC70A188ADAQ36255360-C1334076-6FD3-4431-B254-535E8ACCEF70Q36281328-7CB41E79-4E07-4D7E-8D73-4A3028C8B892Q36856126-51BA6D72-8EB9-40F0-BFD7-E211C3499425Q37226750-3BB5D4AD-7318-4CD4-82BE-AC7ABC82E70EQ37367575-7D0D1D8B-3D35-4514-ABB7-3FDCD4BD40E8Q37444550-2DEA751C-6F1F-47DF-AC7C-8BABAD36BB93
P2860
Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cryptococcus neoformans infect ...... al characteristics and outcome
@ast
Cryptococcus neoformans infect ...... al characteristics and outcome
@en
Cryptococcus neoformans infect ...... al characteristics and outcome
@nl
type
label
Cryptococcus neoformans infect ...... al characteristics and outcome
@ast
Cryptococcus neoformans infect ...... al characteristics and outcome
@en
Cryptococcus neoformans infect ...... al characteristics and outcome
@nl
prefLabel
Cryptococcus neoformans infect ...... al characteristics and outcome
@ast
Cryptococcus neoformans infect ...... al characteristics and outcome
@en
Cryptococcus neoformans infect ...... al characteristics and outcome
@nl
P2093
P2860
P356
P1476
Cryptococcus neoformans infect ...... al characteristics and outcome
@en
P2093
P2860
P304
P356
10.3201/EID0703.010302
P407
P577
2001-01-01T00:00:00Z